Bariatric surgery and its effects on the skin and skin diseases

Obesity Surgery

Volumn 23, Issue 3, 2013, Pages 408-413

  Halawi, Ali ^a   Abiad, Firass ^a   Abbas, Ossama ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Alopecia; Bariatric surgery; Psoriasis; Skin

Indexed keywords

ALOPECIA; ANGIOSARCOMA; BARIATRIC SURGERY; BOWEL ASSOCIATED DERMATOSIS ARTHRITIS SYNDROME; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; HUMAN; MORBID OBESITY; NUTRITIONAL DEFICIENCY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN DISEASE; SYNDROME; TREATMENT RESPONSE; VASCULITIS;

ALOPECIA; ARTHRITIS; BARIATRIC SURGERY; FEMALE; HEMANGIOSARCOMA; HUMANS; MALE; MALNUTRITION; OBESITY, MORBID; PREVALENCE; PSORIASIS; SKIN DISEASES; SYNDROME; VASCULITIS;

EID: 84878857906     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-012-0859-x     Document Type: Review

References (83)

1. World Health Organization. Obesity and overweight. World Health Organization Official Website. Available at http://www.who.int/mediacentre/ factsheets/fs311/en/ Accessed 28 Aug 2012.
2. National Institutes of Health. Gastrointestinal surgery for severe obesity. NIH Consensus Development Program. Available at http://consensus.nih. gov/1991/1991gisurgeryobesity084html.htm. Accessed 28 Aug 2012.
3. Karmali S, Stoklossa CJ, Sharma A, et al. Bariatric surgery: a primer. Can Fam Physician. 2010;56:873-9.
4. Papavramidis ST, Constantinos M. Complications after vertical gastroplasty with artificial pseudopylorus in the treatment of morbid obesity: a 7-year experience. Obes Res. 1999;9:535-8.
5. Mason EE, Renquist KE, Jiang D. Perioperative risks and safety of surgery for severe obesity. Am J Clin Nutr. 1992;55:537S-76S.
6. Rubin M, Benchetrit S, Lustigman H, et al. Laparoscopic gastric banding with Lap-Band for morbid obesity: two-step technique may improve outcome. Obes Surg. 2001;11:315-7.
7. Quigley S, Colledge J, Mukherjee S, et al. Bariatric surgery: a review of normal postoperative anatomy and complications. Clin Radiol. 2011;66:903-14.
8. Dumon KR, Murayama KM. Bariatric surgery outcomes. Surg Clin North Am. 2011;91:1313-38.
9. Snow JM, Severson PA. Complications of adjustable gastric banding. Surg Clin North Am. 2011;91:1249-64.
10. Shipman AR, Millington GW. Obesity and the skin. Br J Dermatol. 2011;165:743-50.
11. Michaels 5th J, Coon D, Rubin JP. Complications in postbariatric body contouring: postoperative management and treatment. Plast Reconstr Surg. 2011;127:1693-700.
12. Freeman JT, Anderson DJ, Hartwig MG, et al. Surgical site infections following bariatric surgery in community hospitals: a weighty concern? Obes Surg. 2011;21:836-40.
13. Alasfar F, Sabnis A, Liu R, et al. Reduction of circular stapler-related wound infection in patients undergoing laparoscopic Roux-en-Y gastric bypass, Cleveland clinic technique. Obes Surg. 2010;20:168-72.
14. Reoch J, Mottillo S, Shimony A, et al. Safety of laparoscopic vs open bariatric surgery: a systematic review and meta-analysis. Arch Surg. 2011;146:1314-22.
15. Skroubis G, Karamanakos S, Sakellaropoulos G, et al. Comparison of early and late complications after various bariatric procedures: incidence and treatment during 15 years at a single institution. World J Surg. 2011;35:93-101.
16. Brolin RE. Prospective, randomized evaluation of midline fascial closure in gastric bariatric operations. Am J Surg. 1996;172:328-31.
17. Shope TR, Cooney RN, McLeod J, et al. Early results after laparoscopic gastric bypass: EEA vs GIA stapled gastrojejunal anastomosis. Obes Surg. 2003;13:355-9.
18. Bussolaro RA, Garcia EB, Zanella MT, et al. Impaired abdominal skin sensory function in morbid obesity and after bariatric surgery. Obes Surg. 2012;22:353-9.
19. de Jongh RT, Serné EH, IJzerman RG, et al. Impaired local microvascular vasodilatory effects of insulin and reduced skin microvascular vasomotion in obese women. Microvasc Res. 2008;75:256-62.
20. Jonk AM, Houben AJ, de Jongh RT, et al. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiology. 2007;22:252-60.
21. Stapleton PA, James ME, Goodwill AG, et al. Obesity and vascular dysfunction. Pathophysiology. 2008;15:79-89.
22. Rossi M, Nannipieri M, Anselmino M, et al. Skin vasodilator function and vasomotion in patients with morbid obesity: effects of gastric bypass surgery. Obes Surg. 2011;21:87-94.
23. Araco A, Gravante G, Araco F, et al. Devastating methicillin resistant Staphylococcus aureus wound infection following abdominoplasty in a prior bariatric surgery patient. Obes Surg. 2007;17:828-31.
24. D'Ettorre M, Gniuli D, Iaconelli A, et al. Wound healing process in post-bariatric patients: an experimental evaluation. Obes Surg. 2010;20:1552-8.
25. Tu J, Chan JJ, Yu LL. Bowel bypass syndrome/bowel-associated dermatosis arthritis syndrome post laparoscopic gastric bypass surgery. Australas J Dermatol. 2011;52(1):e5-7.
26. Patton T, Jukic D, Juhas E. Atypical histopathology in bowel-associated dermatosis-arthritis syndrome: a case report. Dermatol Online J. 2009;15:3.
27. Slater GH, Kerlin P, Georghiou PR, et al. Bowel-associated dermatosis-arthritis syndrome after biliopancreatic diversion. Obes Surg. 2004;14:133-5.
28. Fisch C, Schiller P, Harr T, et al. First presentation of intestinal bypass syndrome 18 yr after initial surgery. Rheumatology. 2001;40:351-3.
29. Katugampola RP, Patel GK, Farrell AM. Intestinal bypass syndrome presenting as erythema nodosum. Clin Exp Dermatol. 2004;29:261-4.
30. Ely PH. The bowel bypass syndrome: a response to bacterial peptidoglycans. J Am Acad Dermatol. 1980;2:473-87.
31. Jorizzo JL, Apisarnthanarax P, Subrt P, et al. Bowel-bypass syndrome without bowel bypass. Bowel-associated dermatosis-arthritis syndrome. Arch Intern Med. 1983;143:457-61.
32. Dicken CH. Bowel-associated dermatosis-arthritis syndrome: bowel bypass syndrome without bowel bypass. J Am Acad Dermatol. 1986;14:792-6.
33. Brouard MC, Chavaz P, Borradori L. Acute pustulosis of the legs in diverticulitis with sigmoid stenosis: an overlap between bowel-associated dermatosis-arthritis syndrome and pustular pyoderma gangrenosum. J Eur Acad Dermatol Venereol. 2004;18:89-92.
34. Callen JP. Neutrophilic dermatoses. Dermatol Clin. 2002;20(3):409-19.
35. Hossler EW, Wood GC, Still CD, et al. The effect of weight loss surgery on the severity of psoriasis. Br J Dermatol. 2013. doi: 10.1111/j.1365-2133. 2012.11211.x
36. Farias MM, Achurra P, Boza C, et al. Psoriasis following bariatric surgery: clinical evolution and impact on quality of life on 10 patients. Obes Surg. 2012;22:877-80.
37. Porres JM. Jejunoileal bypass and psoriasis. Arch Dermatol. 1977;113:983.
38. Hossler EW, Maroon MS, Mowad CM. Gastric bypass surgery improves psoriasis. J Am Acad Dermatol. 2011;65:198-200.
39. Higa-Sansone G, Szomstein S, Soto F, et al. Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg. 2004;14:1132-4.
40. de Menezes Ettinger JE, Azaro E, de Souza CA, et al. Remission of psoriasis after open gastric bypass. Obes Surg. 2006;16:94-7.
41. Pérez-Pérez L, Allegue F, Caeiro JL, et al. Severe psoriasis, morbid obesity and bariatric surgery. Clin Exp Dermatol. 2009;34:e421-2.
42. Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med. 2007;167:1670-5.
43. Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005;141:1527-34.
44. Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol. 2005;125:61-7.
45. Lindegård B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica. 1986;172:298-304.
46. Hamminga EA, van der Lely AJ, Neumann HA, et al. Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses. 2006;67:768-73.
47. Raychaudhuri SP, Gross J. Psoriasis risk factors: role of lifestyle practices. Cutis. 2000;66:348-52.
48. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest. 2003;112:1785-8.
49. Katsuki A, Sumida Y, Murashima S, et al. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1998;83:859-62.
50. Faurschou A, Zachariae C, Skov L, et al. Gastric bypass surgery: improving psoriasis through a GLP-1-dependent mechanism? Med Hypotheses. 2011;77:1098-101.
51. Folope V, Coeffier M, Dechelotte P. Carences nutritionnelles liées à la chirurgie de l'obésité. Gastroenterol Clin Biol. 2007;31:369-77.
52. Xanthakos SA. Nutritional deficiencies in obesity and after bariatric surgery. Pediatr Clin North Am. 2009;56:1105-21.
53. Slater GH, Ren CJ, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8:48-55.
54. Ashourian N, Mousdicas N. Images in clinical medicine. Pellagra-like dermatitis. N Engl J Med. 2006;354:1614.
55. Lopez JF, Halimi S, Perillat Y. Érythème pellagroïde après gastroplastie verticale calibrée pour obésité morbide. Ann Chir. 2000;125:297-8.
56. Ocón J, Cabrejas C, Altemir J, et al. Phrynoderma: a rare dermatologic complication of bariatric surgery. J Parenter Enteral Nutr. 2012;36:361-4.
57. Wechsler HL. Vitamin A, deficiency following small-bowel bypass surgery for obesity. Arch Dermatol. 1979;115:73-5.
58. Barr DJ, Riley RJ, Greco DJ. Bypass phrynoderma: vitamin A deficiency associated with bowel-bypass surgery. Arch Dermatol. 1984;120:919-21.
59. Maronn M, Allen DM, Esterly NB. Phrynoderma: a manifestation of vitamin A deficiency? The rest of the story. Pediatr Dermatol. 2005;22:60-3.
60. Bleasel NR, Stapleton KM, Lee MS, et al. Vitamin A deficiency phrynoderma: due to malabsorption and inadequate diet. J Am Acad Dermatol. 1999;41:322-4.
61. Girard C, Dereure O, Blatière V, et al. Vitamin a deficiency phrynoderma associated with chronic giardiasis. Pediatr Dermatol. 2006;23:346-9.
62. Cone LA, Waterbor BR, Sofonio MV. Purpura fulminans due to Streptococcus pneumoniae sepsis following gastric bypass. Obes Surg. 2004;14:690-4.
63. Lewandowski H, Breen TL, Huang EY. Kwashiorkor and an acrodermatitis enteropathica-like eruption after a distal gastric bypass surgical procedure. Endocr Pract. 2007;13:277-82.
64. Maverakis E, Lynch PJ, Fazel N. Acrodermatitis enteropathica. Dermatol Online J. 2007;13:11.
65. Rojas P, Gosch M, Basfi-fer K, et al. Alopecia in women with severe and morbid obesity who undergo bariatric surgery. Nutr Hosp. 2011;26:856-62.
66. Moreira Mde A, Silva SA, Araújo CM, et al. Avaliaçäo clínico-nutricional de obesos submetidos ao bypass gástrico em Y de Roux. Acta Gastroenterol Latinoam. 2010;40:244-50.
67. Nadler EP, Youn HA, Ginsburg HB, et al. Short-term results in 53 US obese pediatric patients treated with laparoscopic adjustable gastric banding. J Pediatr Surg. 2007;42:137-41.
68. Bobowicz M, Lehmann A, Orlowski M, et al. Preliminary outcomes 1 year after laparoscopic sleeve gastrectomy based on Bariatric Analysis and Reporting Outcome System (BAROS). Obes Surg. 2011;21:1843-8.
69. Neve HJ, Bhatti WA, Soulsby C, et al. Reversal of hair loss following vertical gastroplasty when treated with zinc sulphate. Obes Surg. 1996;6:63-5.
70. Goldberg LJ, Lenzy Y. Nutrition and hair. Clin Dermatol. 2010;28:412-9.
71. Light D, Arvanitis GM, Abramson D, et al. Effect of weight loss after bariatric surgery on skin and the extracellular matrix. Plast Reconstr Surg. 2010;125:343-51.
72. García HL. Dermatological complications of obesity. Am J Clin Dermatol. 2002;3:497-506.
73. Biörserud C, Olbers T, Fagevik OM. Patients' experience of surplus skin after laparoscopic gastric bypass. Obes Surg. 2011;21:273-7.
74. Orpheu SC, Coltro PS, Scopel GP, et al. Collagen and elastic content of abdominal skin after surgical weight loss. Obes Surg. 2010;20:480-6.
75. Danese C, Iuorio A, Iuorio R, et al. Henoch-Schönlein purpura in a patient with bowel bypass syndrome. Clin Ter. 2011;162:e89-92.
76. Ballinger S. Henoch-Schonlein purpura. Curr Opin Rheumatol. 2003;15:591-4.
77. Gamble CN, Kimchi A, Depner TA, et al. Immune complex glomerulonephritis and dermal vasculitis following intestinal bypass for morbid obesity. Am J Clin Pathol. 1982;77:347-52.
78. Goldman JA, Casey HL, Davidson ED, et al. Vasculitis associated with intestinal bypass surgery. Arch Dermatol. 1979;115:725-7.
79. Williams HJ, Samuelson CO, Zone JJ. Nodular nonsuppurative panniculitis associated with jejunoileal bypass surgery. Arch Dermatol. 1979;115:1091-3.
80. Kovaleski CR, Jaliman D, Kumar V, et al. Dermatitis herpetiformis following gastric surgery. Arch Dermatol. 1997;133:113-4.
81. Robinson MR, Honda KS, Bordeaux JS. Angiosarcoma in an obese woman with worsening lymphedema after weight-loss and skin-reduction surgeries. J Am Acad Dermatol. 2011;65:448-9.
82. Young RJ, Brown NJ, Reed MW, et al. Angiosarcoma. Lancet Oncol. 2010;11:983-91.
83. Shon W, Ida CM, Boland-Froemming JM, et al. Cutaneous angiosarcoma arising in massive localized lymphedema of the morbidly obese: a report of five cases and review of the literature. J Cutan Pathol. 2011;38:560-4.